Infosys has extended Tuesday's gains this morning after inking a deal with GlaxoSmithKline to optimize digital channels across its global consumer healthcare and pharma business lines.
The digital marketing platform will allow GSK to build digital assets and listen to consumers across an array of digital channels. The platform will allow teams to collaborate through superior work flow capabilities and foster re-use of digital assets.
The stock opened at Rs 2,885 and surged to a high of Rs 2,915. The stock is now up 1.3% at Rs 1,896. Shares of Infosys had surged 1.5% in trades yesterday. The counter has seen comparatively heft trades of around 38,000 shares so far on the BSE, as against a two-week trading average of 58,000 shares.
